Literature DB >> 9516663

Neuropsychological correlates of positive vs. negative schizophrenic symptomatology.

K K Zakzanis1.   

Abstract

This study attempts to further the validity of the subtype hypothesis in schizophrenia by testing the relationship of neuropsychological functions in schizophrenics with predominantly positive vs. negative symptoms. The Brief Psychiatric Rating Scale (BPRS) was used to parse schizophrenics into positive and negative symptom groups, while a neuropsychological test battery was administered to both types of patients. The results indicate that positive schizophrenic symptomatology is related to frontal executive tasks, whereas negative schizophrenic symptomatology is related to mental tracking tasks that require motoric and dexterous manipulation. However, the absence of non-overlapping symptomatic and neuropsychological functioning groups raises the possibility that a three or more factor model may be more reasonable for reflecting the variety of symptom and neuropsychological patterns in patients, rather than the two-type positive vs. negative dichotomy. The results further the hypothesis that schizophrenia is not a single disease entity.

Entities:  

Mesh:

Year:  1998        PMID: 9516663     DOI: 10.1016/s0920-9964(97)00102-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

2.  Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?

Authors:  Rozmin Halari; Ravi Mehrotra; Tonmoy Sharma; Veena Kumari
Journal:  Schizophr Bull       Date:  2006-06-07       Impact factor: 9.306

3.  From Memories of Past Experiences to Present Motivation? A Meta-analysis on the Association Between Episodic Memory and Negative Symptoms in People With Psychosis.

Authors:  Matthias Pillny; Katarina Krkovic; Laura Buck; Tania M Lincoln
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

4.  Cognitive functioning and negative symptoms in first episode schizophrenia: different patterns of correlates.

Authors:  José Manuel Rodríguez-Sánchez; Benedicto Crespo-Facorro; César González-Blanch; Rocío Pérez-Iglesias; Mario Alvarez-Jiménez; Obdulia Martínez; José Luis Vázquez-Barquero
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

5.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

Review 6.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

7.  Altered spatial profile of distraction in people with schizophrenia.

Authors:  Carly J Leonard; Benjamin M Robinson; Britta Hahn; Steven J Luck; James M Gold
Journal:  J Abnorm Psychol       Date:  2017-11

8.  Cognitive function in schizophrenia and its association with socio-demographics factors.

Authors:  Bharti T Talreja; Sandeep Shah; Lakhan Kataria
Journal:  Ind Psychiatry J       Date:  2013-01

9.  Positive symptoms of schizophrenia and their relationship with cognitive and emotional executive functions.

Authors:  Pamela Ruiz-Castañeda; Encarnación Santiago Molina; Haney Aguirre Loaiza; María Teresa Daza González
Journal:  Cogn Res Princ Implic       Date:  2022-08-12

10.  Neonatal disruption of serine racemase causes schizophrenia-like behavioral abnormalities in adulthood: clinical rescue by d-serine.

Authors:  Hiroko Hagiwara; Masaomi Iyo; Kenji Hashimoto
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.